Skip to main content
construction release_alert
Scholars@Duke will be down for maintenance for approximately one hour starting Tuesday, 11/11 @1pm ET
cancel

Christoph Paul Vincent Hornik

Samuel L. Katz Distinguished Professor of Pediatrics
Pediatrics, Critical Care Medicine
DCRI PO Box 17969, Durham, NC 27715
Dept of Pediatrics, Durham, NC 27710

Current Appointments & Affiliations


Samuel L. Katz Distinguished Professor of Pediatrics · 2024 - Present Pediatrics, Critical Care Medicine, Pediatrics
Professor of Pediatrics · 2023 - Present Pediatrics, Critical Care Medicine, Pediatrics
Chief, Division of Quantitative Sciences · 2018 - Present Pediatrics, Clinical Science Departments
Vice-Chair for Research in the Department of Pediatrics · 2022 - Present Pediatrics, Clinical Science Departments
Membership in the Duke Clinical Research Institute · 2013 - Present Duke Clinical Research Institute, Institutes and Centers

In the News


Published July 3, 2025
Better Health for Teens Starts with Going Places in the Neighborhood
Published March 19, 2024
Duke Awards 32 New Distinguished Professorships for 2024
Published October 7, 2022
New DCRI Center Targets Ending Opioid Addiction

View All News

Recent Publications


Infliximab Pharmacokinetics, Dosing, and Response in Hospitalized Patients with COVID-19 Pneumonia: A Secondary Analysis of a Multinational Randomized Clinical Trial (ACTIV-1 IM).

Journal Article J Clin Pharmacol · November 2025 Infliximab may play an important role in reducing mortality in severe COVID-19, though optimal dosing is unknown. This secondary analysis of the ACTIV-1 IM trial characterized infliximab pharmacokinetics and outcomes in patients hospitalized with severe CO ... Full text Link to item Cite

Population Pharmacokinetics of Alfentanil in Children.

Journal Article J Clin Pharmacol · October 2025 Alfentanil is an opioid analgesic and anesthetic agent used in surgical procedures. Despite its widespread use in children, the U.S. Food and Drug Administration label lacks specific dosing recommendations for those under 12 years. A population pharmacokin ... Full text Link to item Cite

Mpox epidemiology, barriers to treatment and prevention, and perceived stigma: a cross-sectional study.

Journal Article BMC Public Health · September 30, 2025 BACKGROUND: The 2022 mpox outbreak in the United States primarily affected sexual minority men. Barrier to healthcare access, treatment, and vaccination against mpox are not well characterized. Stigma surrounding mpox has not been well quantified, and may ... Full text Link to item Cite
View All Publications

Recent Grants


iPediHeart: Interdisciplinary Research Training Program for Pediatric Heart Disease

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2025 - 2030

2/3 CTSA K12 Program at Duke University

ResearchMentor · Awarded by National Institutes of Health · 2025 - 2030

Teams Engaged in Accessible Mental Health Interventions for Lupus Erythematosus and Dermatomyositis Stress

ResearchCo-Mentor · Awarded by National Institutes of Health · 2025 - 2030

View All Grants

Education, Training & Certifications


University of North Carolina, Chapel Hill · 2019 Ph.D.
University of North Carolina, Chapel Hill · 2012 M.P.H.
Albert Ludwigs University of Freiburg (Germany) · 2005 M.D.